Foal biomarker study finds limited value in predicting Rhodococcus equi pneumonia

Foal biomarker study finds limited value in predicting Rhodococcus equi pneumonia

A prospective cohort study in Equine Veterinary Journal found that serial blood measurements of cytokines, cortisol, and vitamin D from birth to weaning did not reliably predict which foals on a farm endemic for Rhodococcus equi pneumonia would go on to develop subclinical or clinically apparent disease. Investigators followed 200 initially healthy foals, then randomly selected 90 foals across healthy, subclinical, and clinical groups for biomarker analysis. They identified age-related changes across cortisol, vitamin D, and multiple cytokines, plus disease-associated differences in interferon-gamma at 4 and 20 weeks, but overall concluded these circulating markers were not useful predictors of pneumonia susceptibility or severity under field conditions. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For equine veterinarians and farm teams, the findings add to a growing body of evidence suggesting that broad blood-based inflammatory screening may have limited practical value for early identification of foals at risk for endemic bronchopneumonia. A related Equine Veterinary Journal study of 90 foals on the same type of endemic-farm setting likewise found that plasma C-reactive protein and interleukin-6 changed with age, but neither was associated with respiratory disease development from birth to weaning. That points clinicians back toward careful longitudinal monitoring, imaging, and clinical assessment rather than relying on periodic systemic biomarker panels alone. (pmc.ncbi.nlm.nih.gov)

What to watch: The interferon-gamma signal, and newer work on foal immune development and host-directed prevention strategies, could shape the next wave of targeted biomarker or immunomodulation studies. (pubmed.ncbi.nlm.nih.gov)